Details for New Drug Application (NDA): 205695
✉ Email this page to a colleague
The generic ingredient in MONTELUKAST SODIUM is montelukast sodium. There are thirty-five drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the montelukast sodium profile page.
Summary for 205695
| Tradename: | MONTELUKAST SODIUM |
| Applicant: | Anbison Lab |
| Ingredient: | montelukast sodium |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, CHEWABLE;ORAL | Strength | EQ 4MG BASE | ||||
| Approval Date: | Nov 5, 2015 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, CHEWABLE;ORAL | Strength | EQ 5MG BASE | ||||
| Approval Date: | Nov 5, 2015 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
